TY - GEN
AU - Qi, Xiaolong
AU - Liu, Yanna
AU - Wang, Jitao
AU - Fallowfield, Jonathan A.
AU - Wang, Jianwen
AU - Li, Xinyu
AU - Shi, Jindong
AU - Pan, Hongqiu
AU - Zou, Shengqiang
AU - Zhang, Hongguang
AU - Chen, Zhenhuai
AU - Li, Fujian
AU - Luo, Yan
AU - Mei, Mei
AU - Liu, Huiling
AU - Wang, Zhengyan
AU - Li, Jinlin
AU - Yang, Hua
AU - Xiang, Huihua
AU - Li, Xiaodan
AU - Liu, Tao
AU - Zheng, Ming-Hua
AU - Liu, Chuan
AU - Huang, Yifei
AU - Xu, Dan
AU - Li, Xiaoguo
AU - Kang, Ning
AU - He, Qing
AU - Gu, Ye
AU - Zhang, Guo
AU - Shao, Chuxiao
AU - Liu, Dengxiang
AU - Zhang, Lin
AU - Li, Xun
AU - Kawada, Norifumi
AU - Jiang, Zicheng
AU - Wang, Fengmei
AU - Xiong, Bin
AU - Takehara, Tetsuo
AU - Rockey, Don C.
PY - 2020
DA - May
TI - Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study
EP - 436
VL - 70
IS - 2
DO - https://doi.org/10.1136/gutjnl-2020-321666
AB - In this study we provide the first report of the characteristics, comorbidities, laboratory and x-ray findings, and clinical outcomes in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected patients with pre-existing liver cirrhosis. The cause of death in most patients was respiratory failure rather than progression of liver disease. Lower numbers of blood lymphocytes and platelets, and higher bilirubin levels might represent indicators of poor outcome in this patient population.
PB - BMJ Publishing Group
UR - https://www.research.ed.ac.uk/portal/en/publications/clinical-course-and-risk-factors-for-mortality-of-covid19-patients-with-preexisting-cirrhosis-a-multicentre-cohort-study(198d3ffd-5092-42c1-ba27-4757f2325151).html
KW - Coronavirus (COVID-19)
ER